Company intelligence / Profile preview

Bicosome

Ownership: Private
Development stage: Commercial

Overview

Bicosome has commercialized its proprietary nanostructured lipid-based ingredient delivery systems for use in cosmetic and dermo-pharmaceutical products. The company’s technology enables effective penetration and targeted release of active agents into specific layers of the skin. Recent collaborations have expanded their IP portfolio with new biomimetic gel technologies, expected to reach market within two years.

No clinical trial results are reported as the company operates primarily in cosmetics/dermo-pharma rather than regulated pharmaceuticals.

Therapeutic areas: Dermatology
Modalities: Small molecules (active ingredients)Nanostructured lipid carriers (delivery system)Biomimetic gels (lipid-based delivery)
Industry: Non-Drug Biotech

Drug pipeline

3 assets

Bicobiome Skin

Commercial

Indications: Skin microbiome

2 more assets in the full pipeline.

Request access →

Partnerships

Institute of Advanced Chemistry of Catalonia (IQAC), Spanish National Research Council (CSIC) – long-term R&D collaboration/licensing partner for new patents/platforms.

Beyond the preview

Go deeper on Bicosome.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bicosome.

Explore the full profile